INS and diabetic macular edema: A recent retrospective cohort analysis revealed that, compared to the combination of SGLT-2 inhibitors with insulin, the concomitant use of GLP-1RAs and insulin was associated with a significantly elevated risk of DR and diabetic macular edema [80].